JAMES T. LAFRANCE - Corporate Board Profile

Aspira Women's Health Inc.

Filing Date	Source Excerpt
2014-04-29	James T. LaFrance was appointed our President and Chief Executive Officer effective April 23, 2014. ... The compensation earned by our outside directors for the year ended December 31, 2013 was as follows: James T. LaFrance ... Total $0. ... James T. LaFrance is not an independent director because he serves as our President and Chief Executive Officer.
2015-04-29	James T. LaFrance, age 56, was elected to our Board of Directors in December 2013 and was also appointed Chairman of our Board. ... The table below presents the compensation earned by our outside directors for the year ended December 31, 2014... Mr. LaFrance ceased receiving compensation for his 2014 service as a director effective April 23, 2014.
2016-04-29	James T. LaFrance, age 57, was elected to our Board of Directors in December 2013 and was also appointed Chairman of our Board. ... The table below presents the compensation earned by our outside directors for the year ended December 31, 2015. ... James LaFrance Fees Earned or Paid in Cash: $32,700, Stock Awards: $80,233, Total: $112,933.
2017-04-27	James T. LaFrance, age 58, was appointed to our Board of Directors in December 2013 and was also appointed Chairman of our Board. ... During 2016, the outside directors were compensated as follows, with the RSU or RSU/cash awards being made as of March 17, 2016: the Chairman of the Board was awarded 45,455 RSUs and $30,000... 2016 Director Compensation Table ... James T. LaFrance Fees Earned or Paid in Cash $32,700, Stock Awards $76,300, All Other Compensation $0, Total $109,000.
2018-05-11	James T. LaFrance, age 59, was appointed to our Board of Directors in December 2013 and was also appointed Chairman of our Board. Mr. LaFrance was initially designated as a director nominee pursuant to the Stockholders Agreement described under “Certain Relationships and Related Transactions” below.
2019-05-09	James T. LaFrance, age 60, was appointed to our Board in December 2013 and was also appointed Chairman of our Board. ... Our Board has determined that based upon Mr. LaFrance’s demonstrated executive-level management and commercial operations skills, as well as his prior role as our President and Chief Executive Officer and his prior board position, he has the qualifications and skills to serve as a member and the Chairman of our Board. ... 2018 Director Compensation Table ... James T. LaFrance ... $121,250.
2020-04-27	James T. LaFrance, age 61, was appointed to our Board in December 2013 and was also appointed Chairman of our Board.
2021-05-07	James T. LaFrance, age 62, was appointed to our Board in December 2013 and was also appointed Chairperson of our Board. Mr. LaFrance was initially designated as a director nominee pursuant to the Stockholders Agreement described under “Certain Relationships and Related Transactions” below. He also served as our President and Chief Executive Officer from April 2014 to December 2014. Mr. LaFrance has over thirty years of diagnostic industry experience. From May 2012 to September 2013, Mr. LaFrance was head of digital pathology and acting Chief Executive Officer of Omnyx, LLC for GE Healthcare, a medical technology provider. From 2009 to 2011, Mr. LaFrance was the President and Chief Executive Officer of LaFrance Consulting, an independent consulting firm. Prior to that, Mr. LaFrance held a series of commercial, strategic marketing and business development leadership roles at Ventana Medical Systems, Inc. (now Roche Tissue Diagnostics), a provider of tissue-based diagnostic solutions, including general manager of their North American and International commercial organizations from 2001 to 2009. Prior to Ventana, Mr. LaFrance served in leadership roles in strategic marketing and business development at Bayer Diagnostics. He currently serves as a member of the boards of HTG Molecular, Inc. and Personal Genome Diagnostics, Inc. He earned a Bachelor of Arts degree in Economics from the University of Connecticut and an M.B.A. from the University of Notre Dame. Our Board has determined that based upon Mr. LaFrance’s demonstrated executive-level management and commercial operations skills, as well as his prior role as our President and Chief Executive Officer and his prior board position, he has the qualifications and skills to serve as a member and the Chairperson of our Board and Chairperson of our Nominating and Governance Committee. The table below presents the compensation earned by our outside directors for the year ended December 31, 2020. James T. LaFrance compensation: $206,981.
2022-04-29	James T. LaFrance, age 63, was appointed to our Board in December 2013. He served as Chair of our Board from that date until his appointment as Lead Independent Director effective March 2022. He was designated as a director nominee pursuant to the Stockholders Agreement.